vs

Side-by-side financial comparison of CuriosityStream Inc. (CURI) and Idaho Strategic Resources, Inc. (IDR). Click either name above to swap in a different company.

CuriosityStream Inc. is the larger business by last-quarter revenue ($19.2M vs $14.6M, roughly 1.3× Idaho Strategic Resources, Inc.). Idaho Strategic Resources, Inc. runs the higher net margin — 64.3% vs -19.7%, a 84.0% gap on every dollar of revenue. On growth, Idaho Strategic Resources, Inc. posted the faster year-over-year revenue change (92.0% vs 35.8%). Idaho Strategic Resources, Inc. produced more free cash flow last quarter ($8.2M vs $3.9M). Over the past eight quarters, Idaho Strategic Resources, Inc.'s revenue compounded faster (57.2% CAGR vs 26.5%).

Curiosity Stream Inc., formerly branded as CuriosityStream, is an American media company and over-the-top subscription video streaming service which offers documentary programming including films, series, and TV shows. The company offers a video on demand subscription service branded as "Curiosity Stream" and a linear broadcast television channel known as the Curiosity Channel through various services including FuboTV and The Roku Channel.

Idaho Strategic Resources, Inc. is a U.S.-based natural resource company focused on the exploration, development, and production of critical and strategic minerals. Primarily operating in Idaho, it targets rare earth elements, gold, silver, and other high-demand minerals, supplying products to the clean energy, defense, and industrial manufacturing sectors across North America.

CURI vs IDR — Head-to-Head

Bigger by revenue
CURI
CURI
1.3× larger
CURI
$19.2M
$14.6M
IDR
Growing faster (revenue YoY)
IDR
IDR
+56.2% gap
IDR
92.0%
35.8%
CURI
Higher net margin
IDR
IDR
84.0% more per $
IDR
64.3%
-19.7%
CURI
More free cash flow
IDR
IDR
$4.2M more FCF
IDR
$8.2M
$3.9M
CURI
Faster 2-yr revenue CAGR
IDR
IDR
Annualised
IDR
57.2%
26.5%
CURI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CURI
CURI
IDR
IDR
Revenue
$19.2M
$14.6M
Net Profit
$-3.8M
$9.4M
Gross Margin
68.5%
Operating Margin
-17.6%
62.4%
Net Margin
-19.7%
64.3%
Revenue YoY
35.8%
92.0%
Net Profit YoY
-34.6%
220.6%
EPS (diluted)
$-0.07
$0.62

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CURI
CURI
IDR
IDR
Q4 25
$19.2M
$14.6M
Q3 25
$18.4M
$11.1M
Q2 25
$19.0M
$9.5M
Q1 25
$15.1M
$7.3M
Q4 24
$14.1M
$7.6M
Q3 24
$12.6M
$6.2M
Q2 24
$12.4M
$6.1M
Q1 24
$12.0M
$5.9M
Net Profit
CURI
CURI
IDR
IDR
Q4 25
$-3.8M
$9.4M
Q3 25
$-3.7M
$3.0M
Q2 25
$784.0K
$2.8M
Q1 25
$319.0K
$1.6M
Q4 24
$-2.8M
$2.9M
Q3 24
$-3.1M
$1.6M
Q2 24
$-2.0M
$2.2M
Q1 24
$-5.0M
$2.2M
Gross Margin
CURI
CURI
IDR
IDR
Q4 25
68.5%
Q3 25
63.6%
Q2 25
57.8%
Q1 25
50.8%
Q4 24
53.3%
Q3 24
48.7%
Q2 24
50.2%
Q1 24
48.1%
Operating Margin
CURI
CURI
IDR
IDR
Q4 25
-17.6%
62.4%
Q3 25
-24.5%
23.4%
Q2 25
2.5%
26.6%
Q1 25
0.5%
19.3%
Q4 24
-27.4%
36.2%
Q3 24
-25.8%
23.4%
Q2 24
-20.6%
34.2%
Q1 24
-30.4%
36.3%
Net Margin
CURI
CURI
IDR
IDR
Q4 25
-19.7%
64.3%
Q3 25
-20.4%
26.8%
Q2 25
4.1%
29.2%
Q1 25
2.1%
22.1%
Q4 24
-19.9%
38.5%
Q3 24
-24.3%
25.8%
Q2 24
-16.4%
35.2%
Q1 24
-42.0%
36.8%
EPS (diluted)
CURI
CURI
IDR
IDR
Q4 25
$-0.07
$0.62
Q3 25
$-0.06
$0.20
Q2 25
$0.01
$0.20
Q1 25
$0.01
$0.12
Q4 24
$-0.05
$0.21
Q3 24
$-0.06
$0.12
Q2 24
$-0.04
$0.17
Q1 24
$-0.09
$0.17

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CURI
CURI
IDR
IDR
Cash + ST InvestmentsLiquidity on hand
$27.3M
Total DebtLower is stronger
$2.3M
Stockholders' EquityBook value
$41.5M
$108.2M
Total Assets
$75.7M
$116.2M
Debt / EquityLower = less leverage
0.02×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CURI
CURI
IDR
IDR
Q4 25
$27.3M
Q3 25
$27.8M
Q2 25
$28.1M
Q1 25
$33.4M
Q4 24
$32.1M
Q3 24
$33.2M
Q2 24
$39.5M
$6.3M
Q1 24
$38.8M
$5.3M
Total Debt
CURI
CURI
IDR
IDR
Q4 25
$2.3M
Q3 25
$3.0M
Q2 25
$3.3M
Q1 25
$3.7M
Q4 24
$1.7M
Q3 24
$2.9M
Q2 24
$2.7M
Q1 24
$3.3M
Stockholders' Equity
CURI
CURI
IDR
IDR
Q4 25
$41.5M
$108.2M
Q3 25
$47.2M
$74.3M
Q2 25
$49.8M
$49.3M
Q1 25
$58.1M
$39.8M
Q4 24
$57.8M
$37.7M
Q3 24
$62.2M
$33.1M
Q2 24
$64.8M
$25.4M
Q1 24
$67.0M
$21.6M
Total Assets
CURI
CURI
IDR
IDR
Q4 25
$75.7M
$116.2M
Q3 25
$74.7M
$83.1M
Q2 25
$78.7M
$57.7M
Q1 25
$85.3M
$48.1M
Q4 24
$86.2M
$44.0M
Q3 24
$87.6M
$40.8M
Q2 24
$90.9M
$32.2M
Q1 24
$94.6M
$28.7M
Debt / Equity
CURI
CURI
IDR
IDR
Q4 25
0.02×
Q3 25
0.04×
Q2 25
0.07×
Q1 25
0.09×
Q4 24
0.05×
Q3 24
0.09×
Q2 24
0.11×
Q1 24
0.15×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CURI
CURI
IDR
IDR
Operating Cash FlowLast quarter
$4.0M
$10.7M
Free Cash FlowOCF − Capex
$3.9M
$8.2M
FCF MarginFCF / Revenue
20.5%
56.0%
Capex IntensityCapex / Revenue
0.1%
17.7%
Cash ConversionOCF / Net Profit
1.15×
TTM Free Cash FlowTrailing 4 quarters
$12.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CURI
CURI
IDR
IDR
Q4 25
$4.0M
$10.7M
Q3 25
$4.4M
$2.4M
Q2 25
$2.8M
$3.5M
Q1 25
$1.9M
$2.4M
Q4 24
$3.0M
$3.2M
Q3 24
$2.3M
$2.5M
Q2 24
$2.2M
$2.6M
Q1 24
$666.0K
$2.6M
Free Cash Flow
CURI
CURI
IDR
IDR
Q4 25
$3.9M
$8.2M
Q3 25
$709.8K
Q2 25
$2.5M
Q1 25
$1.8M
$1.0M
Q4 24
$2.1M
Q3 24
$1.9M
Q2 24
$2.4M
Q1 24
$2.3M
FCF Margin
CURI
CURI
IDR
IDR
Q4 25
20.5%
56.0%
Q3 25
6.4%
Q2 25
26.5%
Q1 25
12.2%
13.8%
Q4 24
28.0%
Q3 24
30.4%
Q2 24
38.7%
Q1 24
38.3%
Capex Intensity
CURI
CURI
IDR
IDR
Q4 25
0.1%
17.7%
Q3 25
0.0%
15.3%
Q2 25
0.0%
10.8%
Q1 25
0.5%
19.4%
Q4 24
0.0%
13.6%
Q3 24
0.0%
9.8%
Q2 24
0.0%
4.3%
Q1 24
0.0%
5.5%
Cash Conversion
CURI
CURI
IDR
IDR
Q4 25
1.15×
Q3 25
0.81×
Q2 25
3.56×
1.28×
Q1 25
6.03×
1.50×
Q4 24
1.08×
Q3 24
1.56×
Q2 24
1.22×
Q1 24
1.19×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons